clarithromycin should not be used in the setting of hypokalaemia ( low blood potassium ) use of clarithromycin with the following medications : cisapride , pimozide , astemizole , terfenadine , ergotamine , ticagrelor , ranolazine or dihydroergotamine is not recommended concomitant use with cholesterol medications such as lovastatin or simvastatin qt prolongation or ventricular cardiac arrhythmias , including torsade de pointes it also can cause headaches , insomnia , and abnormal liver function tests nippon naika gakkai zasshi in one trial , the use of short-term clarithromycin treatment was correlated with an increased incidence of deaths classified as sudden cardiac deaths in stable coronary heart disease patients not using statins concurrent therapy with calcium channel blocker may increase risk of hypotension , kidney failure , and death , compared to pairing calcium channel blockers with azithromycin , a drug similar to clarithromycin but without cyp3a4 inhibition depending on the combination of medications , clarithromycin therapy could be contraindicated , require changing doses of some medications , or be acceptable without dose adjustments clarithromycin prevents bacteria from multiplying by acting as a protein synthesis inhibitor it is readily absorbed , and diffuses into most tissues and phagocytes its major metabolites include an inactive metabolite , n-desmethylclarithromycin , and an active metabolite , 14- ( r ) -hydroxyclarithromycin taisho filed for patent protection for the drug around 1980 and subsequently introduced a branded version of its drug , called clarith , to the japanese market in 1991 the drug went generic in europe in 2004 and in the us in mid-2005